CellFiber

CellFiber

Cell Culture Reimagined

Founded 2015 Japan

Japan 10 employees Series A Total: $943.00M Biotechnology, Medical Devices

CellFiber Co., Ltd. is revolutionizing the field of cell culture with their innovative platform technology, CellFiber™. This technology enables higher yields and product quality while ensuring stability, predictability, reproducibility, and scalability for cell and gene therapy applications. The company's focus on lowering costs and development timelines positions it as a game-changer in the biotechnology industry. The unique CellFiber™ technology, which consists of hollow and permeable alginate hydrogel outer shells and a cell-rich core region, allows for high-density cell culture, cost reduction, and scalable culture methods for commercial manufacturing. CellFiber Co., Ltd. has been developing scale-up manufacturing processes for various cells and vectors, with potential applications in multiple therapeutic areas. In terms of investment, the company recently secured a significant ¥830.00M Venture Round investment on 09 November 2023, with participation from JAFCO Japan, Real Tech Holdings, Universal Materials Incubator, Fast Track Initiative, Inc., and Chiba Dojo. This substantial investment reflects the confidence of industry players in the potential of CellFiber Co., Ltd. and its disruptive technology. As the company continues to develop its GMP CellFiber™ Extruders and expand its partnerships with CMOs, CDMOs, therapeutic companies, and pharmaceutical companies, it is poised for significant growth and impact in the biotechnology sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	¥830.00M	5	JAFCO Japan, Real Tech Holdings +3	09 Nov 2023
Series A	$3.10M	2	Daiwa Corporate Investment, Real Tech Holdings	12 May 2022
Seed Round	¥105.00M	1	Real Tech Holdings	14 Oct 2020
Venture Round	¥4.90M	1	Glocalink	22 Dec 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

¥830.00M

JAFCO Japan, Real Tech Holdings +3

09 Nov 2023

Series A

$3.10M

Daiwa Corporate Investment, Real Tech Holdings

12 May 2022

Seed Round

¥105.00M

Real Tech Holdings

14 Oct 2020

Venture Round

¥4.90M

Glocalink

22 Dec 2017

FAQ About CellFiber

Cell Culture Reimagined

CellFiber was founded in 2015.

CellFiber is headquartered in Japan.

CellFiber operates in Biotechnology and Medical Devices. Its work centres on biomanufacturing, cell culture, cell therapy and gene therapy.

CellFiber has approximately 10 employees.

CellFiber has completed 4 funding rounds, raising a total of $943.00M. The latest funding stage is Series A.

Top alternatives and competitors to CellFiber include PBS Biotech, Histocell. Regenerative Medicine, Abeona Therapeutics, Imunopharm Technology, RareCyte, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

CellFiber and PBS Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About CellFiber

Funding Rounds & Investors (4)

CellFiber Alternatives & Competitors

FAQ About CellFiber